A clinical trial to study the effect of individualized homoeopathic medicines in treating patients diagnosed with Nasal Polyp.
Phase 2
- Conditions
- Health Condition 1: J330- Polyp of nasal cavity
- Registration Number
- CTRI/2023/11/060087
- Lead Sponsor
- idhi P Shenoi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with positive anterior rhinoscopic examination findings for Nasal polyp.
Exclusion Criteria
1. Patient who had taken topical steroids within 4 weeks before the study therapy (shall be
enrolled after a washout period of 2 weeks)
2. Patients with craniofacial deformities.
3. Patients with known immunodeficiency diseases
4. Pregnant and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the Nasal polyp grade using Meltzer clinical scoring system on anterior rhinoscopic <br/ ><br>examination.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method Changes in NOSE scale score. <br/ ><br>Timepoint: 1 year